Clinical Research News Online

How the Pharma Industry Can Solve Common Clinical Trial Bottlenecks
Jan 18 | Clinical Research News | The race to develop a COVID-19 vaccine has shone a light on the sometimes complex process of getting a drug to market like never before, providing an opportune time to examine several common bottlenecks associated with clinical trials and what the industry can do to alleviate them. More
Myocarditis Not Common Among Athletes, Pediatric Hospitalizations Rising, Gut Microbiome Influences Severity: COVID-19 Updates
Jan 15 | Clinical Research News I COVID-19 ICU patients experience higher rates of delirium and coma, ABM recommends women continue breastfeeding after vaccination, Wuhan study finds lingering symptoms in many, immunosuppressed patients show similar outcomes, and ICU nurses suffer toll on mental health. Plus: Princeton University spin-off launches AI COVID screening tool and poor mental health could impact vaccine effectiveness. More
Parexel Ejects Informatics Business, Calyx Launches
Jan 11 | Clinical Research News |Parexel today announced the completion of the separation of its Parexel Informatics and Medical Imaging business from the parent company. Parexel Informatics becomes Calyx, a provider of medical imaging, eClinical, and regulatory solutions and services to solve complex challenges in clinical research. More
Virtual Trials Should Not Mean Siteless Trials
Jan 11 | Clinical Research News | Growth in decentralized clinical trials and an increasingly impressive list of features and functionality associated with remote patient monitoring and engagement technologies are making the promises of so-called Virtual Clinical Trials closer to reality than ever. But should Virtual Trials mean siteless trials? Removing sites from the equation, on paper, seems like a win, leading to lower costs and more convenience. However, with patient compliance still posing a significant challenge for sponsors, removing the personal connection and accountability checks provided by site teams can place the entire study in jeopardy. More
Umbilical Stem Cells Promising Treatment, Long Term Impacts on Brain, Smart Vaccine Patch Under Development: COVID-19 Updates
Jan 08 | Clinical Research News I Pfizer funds long-term safety study on their COVID-19 vaccine, Phase 3 clinical trial results show Moderna’s vaccine is both effective and safe, Radx-rad program supports innovative approaches to gaps in testing and surveillance. Plus: Protective immunity could last several months, and more. More
Trendspotting: Decentralized Trials, AI, Real-World Data in 2021
Jan 07 | Clinical Research News | We gathered predictions from leaders in clinical research who are working hard to synthesize what 2020 brought us and apply learnings to 2021. More
MSK Researchers Find Immunotherapy May Be A Good Option For BRCA2 Tumors
Jan 06 | Clinical Research News | Despite having similar levels of tumor mutational burden, cancers associated with BRCA1 and BRCA2 alterations respond quite differently to immunotherapy. Counterintuitively, the tumor type that typically harbors the fewer number of immune cells—BRCA2—appears to be more immunogenic and the reason may be that the mutation process generates foreign-looking peptides readily detected by the body’s DNA repair engine. More
Gamifying Eye Health, Heavy Investments, Acquisitions in Decentralized Trials, More
Jan 04 | Clinical Research News | Launch of the Decentralized Trials & Research Alliance, acquisitions focused on decentralized trials and remote administration, new wearables for remote monitoring, better training for nurses in clinical settings, and more. More
Top Stories of 2020: Real-World Data, Research Ethics, and Virtual Trials. And COVID-19
Dec 29 | Clinical Research News | This year clinicians everywhere have worked to understand COVID-19, but that wasn’t the only disease we were concerned about. Crucial research on cancer, rare diseases, and many other indications was put on hold while sponsors and CROs re-envisioned clinical trials virtually and worked to reassure participants that they were safe at sites. More
The Pandemic Has Proven a New Approach to Clinical Trials is Necessary
Dec 22 | Clinical Research News | The COVID-19 pandemic has accelerated the need for a new approach to how clinical trial teams work with patients. At the onslaught of the health crisis, restrictions, and heavy precautions on personal interactions brought clinical trials to a veritable standstill. This left the life sciences industry looking for alternative ways to maintain patient participation in clinical trials, primarily, as it relates to patient interaction and data collection. More

Shimmer’s Verisense® Wearable Sensing Platform Selected for Boston University Brain Health Studies
Jan 19 | These studies, which are funded by the American Heart Association, will use wearable sensors to increase knowledge of the links between brain and heart health. More
‘UK government can deliver Brexit benefit with world’s best medicines security’ say FarmaTrust
Jan 19 | Company forewarns the UK is risking fake COVID-19 vaccines and other medicines without a new system More
Gut Microbiota Bioinformatics Services Now Available by the GutFlora Omics Platform
Jan 19 | GutFlora Omics platform belongs to Creative Proteomics. It has more than 10 years of experience in providing advanced multi-omics services, and provides services and support to customers through comprehensive intestinal flora research solutions. The product manager has recently announced the fully-developed gut microbiota bioinformatics services, which help understand how the gut microbiota colonizes, varies and interacts with the host, and even how to associate with diseases can be of great value in the treatment of these diseases, such as inflammatory bowel disease (IBD), diabetes, mental disorders, and cancers. More
RheinCell Therapeutics Achieves Milestone GMP Certification to Manufacture Cord Blood-Derived iPSCs for Safe and Compliant Cell Therapies
Jan 19 | RheinCell Therapeutics GmbH, a developer and manufacturer of human induced pluripotent stem cells (iPSCs) as starting materials for cell therapies, has announced it has received Good Manufacturing Practice (GMP) certification and Manufacturing Authorization. The GMP certification paves the way for the company to deliver fully characterized clinical-grade iPSCs that are derived from human cord blood cells for the development of cell-based therapies. This marks a landmark achievement for RheinCell, which is now among a select few iPSCs manufacturers to have received the critical certification. More
Global healthtech company Raremark appoints Nicki Grundy as its Chief Financial Officer
Jan 19 | Raremark, the global healthtech company specialising in rare disease, has appointed Nicki Grundy as Chief Financial Officer to support the accelerated levels of growth the company is experiencing. More
Ubiquigent and the University of York Awarded a Grant to Explore the Potential of Deubiquitylase (DUB) Enzyme Inhibitors to Address Neglected Tropical Diseases
Jan 19 | Ubiquigent today announced a collaboration with Mottram Laboratory at the University of York to investigate the inhibition of deubiquitylase (DUB) enzymes expressed by the protozoan Leishmania mexicana for the treatment of leishmaniasis. More
Pronalyse Division Announced Vaccines Analysis Service to Ensure Vaccine Safety
Jan 19 | Pronalyse is a new division of Creative Proteomics, which is an integrated CRO company with rich experience in providing drug development service for over 10 years. Pronalyse is dedicated to providing professional analysis services in biopharmaceutical development. Recently, the product manager has announced the vaccines analysis service to ensure the safety, efficacy, purity and potency of vaccine products. More
MedAI: Explore Therapeutic Antibody Discovery and Development for Disease Treatment
Jan 19 | Bio-drugs are more extensively used in disease treatment, especially in the past decade. MedAI, an expert of AI-assisted R&D research company, announces that it now provides AI-driven solutions for the development of therapeutic antibodies, which could be used for the treatment of pathologies such as oncology. More
Alfa Chemistry: Instrumental Analytical Reagents Are Now Accessible
Jan 19 | Alfa Chemistry announced in a statement that the company starts to provide varieties of instrumental analytical reagents for consumers worldwide. In addition to other reagents that are previously released, now the company’s supply range of products are widely broadened, which encompasses: chromatography standards and derivatization reagents, Ion Sensor Materials, Laboratory Supplies, LPLC/TLC/Paper Chromatography, and Titration. More
BOC Sciences’s CDMO Helps Overcome the Last Hurdle of ADC R&D
Jan 11 | More

View more articles

DIA's Pharmacovigilance and Risk Management Strategies Conference provides the foundation for strong strategic planning and practical decision-making in pharmacovigilance programs. Developed by recognized experts from the biopharmaceutical industry and global regulatory agencies, this conference provides the background, context, and opportunities to discuss current challenges and to problem-solve around issues that matter most to professionals working in the field.

Barnett International offers comprehensive role-based training for clinical research professionals worldwide. Learn how you can leverage Barnett’s numerous resources for your teams!

Tweets by @Clin_Info_News